The following article was featured in:
Source:
Dallas Health Care RSS Feed
07/01/2025.
Employers are grappling with the ripple effect of an increasingly popular weight loss treatment. Glucagon-like peptide 1 (GLP-1) receptor agonists are a favored treatment for type-2 diabetes but have...
Continue on to full article...
